Today's Daily Dose brings you news about Tonix Pharma's update on PTSD trial, Merck's Q4 financial results, BioXcel's progress made in its RELEASE trial, Biogen's patent win over Mylan, and Cardiovascular Systems' fiscal second-quarter financial results.
Original Article: BTAI Hits A High, TNXP's RECOVERY Fails, MRK Plans A Spin-off